Table of Content

Chapter 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
Chapter 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
Chapter 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Moderate bargaining power of suppliers
3.3.2. Moderate threat of new entrants
3.3.3. Moderate threat of substitutes
3.3.4. Moderate intensity of rivalry
3.3.5. High bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in prevalence of chronic and infectious diseases
3.4.1.2. Surge in awareness about early disease diagnosis and personalized medicine
3.4.1.3. Rise in number of diagnostic laboratories
3.4.2. Restraints
3.4.2.1. Stringent regulatory policies
3.4.3. Opportunities
3.4.3.1. Technological advancements in IVD
Chapter 4: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES
4.1. Overview
4.1.1. Market size and forecast
4.2. Reagents and Kits
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Instruments
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Software and Services
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
Chapter 5: IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE
5.1. Overview
5.1.1. Market size and forecast
5.2. Immunodiagnostics
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Hematology
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Molecular Diagnostics
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Tissue Diagnostics
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
5.6. Clinical Chemistry
5.6.1. Key market trends, growth factors and opportunities
5.6.2. Market size and forecast, by region
5.6.3. Market share analysis by country
5.7. Others
5.7.1. Key market trends, growth factors and opportunities
5.7.2. Market size and forecast, by region
5.7.3. Market share analysis by country
Chapter 6: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION
6.1. Overview
6.1.1. Market size and forecast
6.2. Infectious Diseases
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Cancer
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Cardiac Diseases
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
6.5. Immune System Disorders
6.5.1. Key market trends, growth factors and opportunities
6.5.2. Market size and forecast, by region
6.5.3. Market share analysis by country
6.6. Nephrological Diseases
6.6.1. Key market trends, growth factors and opportunities
6.6.2. Market size and forecast, by region
6.6.3. Market share analysis by country
6.7. Gastrointestinal Diseases
6.7.1. Key market trends, growth factors and opportunities
6.7.2. Market size and forecast, by region
6.7.3. Market share analysis by country
6.8. Others
6.8.1. Key market trends, growth factors and opportunities
6.8.2. Market size and forecast, by region
6.8.3. Market share analysis by country
Chapter 7: IN VITRO DIAGNOSTICS MARKET, BY END USER
7.1. Overview
7.1.1. Market size and forecast
7.2. Standalone Laboratories
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by region
7.2.3. Market share analysis by country
7.3. Hospitals
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by region
7.3.3. Market share analysis by country
7.4. Academic and Medical Schools
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by region
7.4.3. Market share analysis by country
7.5. Point of Care
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by region
7.5.3. Market share analysis by country
7.6. Others
7.6.1. Key market trends, growth factors and opportunities
7.6.2. Market size and forecast, by region
7.6.3. Market share analysis by country
Chapter 8: IN VITRO DIAGNOSTICS MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast By Region
8.2. North America
8.2.1. Key market trends, growth factors and opportunities
8.2.2. Market size and forecast, by Product and Services
8.2.3. Market size and forecast, by Technique
8.2.4. Market size and forecast, by Application
8.2.5. Market size and forecast, by End User
8.2.6. Market size and forecast, by country
8.2.6.1. U.S.
8.2.6.1.1. Market size and forecast, by Product and Services
8.2.6.1.2. Market size and forecast, by Technique
8.2.6.1.3. Market size and forecast, by Application
8.2.6.1.4. Market size and forecast, by End User
8.2.6.2. Canada
8.2.6.2.1. Market size and forecast, by Product and Services
8.2.6.2.2. Market size and forecast, by Technique
8.2.6.2.3. Market size and forecast, by Application
8.2.6.2.4. Market size and forecast, by End User
8.2.6.3. Mexico
8.2.6.3.1. Market size and forecast, by Product and Services
8.2.6.3.2. Market size and forecast, by Technique
8.2.6.3.3. Market size and forecast, by Application
8.2.6.3.4. Market size and forecast, by End User
8.3. Europe
8.3.1. Key market trends, growth factors and opportunities
8.3.2. Market size and forecast, by Product and Services
8.3.3. Market size and forecast, by Technique
8.3.4. Market size and forecast, by Application
8.3.5. Market size and forecast, by End User
8.3.6. Market size and forecast, by country
8.3.6.1. Germany
8.3.6.1.1. Market size and forecast, by Product and Services
8.3.6.1.2. Market size and forecast, by Technique
8.3.6.1.3. Market size and forecast, by Application
8.3.6.1.4. Market size and forecast, by End User
8.3.6.2. France
8.3.6.2.1. Market size and forecast, by Product and Services
8.3.6.2.2. Market size and forecast, by Technique
8.3.6.2.3. Market size and forecast, by Application
8.3.6.2.4. Market size and forecast, by End User
8.3.6.3. UK
8.3.6.3.1. Market size and forecast, by Product and Services
8.3.6.3.2. Market size and forecast, by Technique
8.3.6.3.3. Market size and forecast, by Application
8.3.6.3.4. Market size and forecast, by End User
8.3.6.4. Italy
8.3.6.4.1. Market size and forecast, by Product and Services
8.3.6.4.2. Market size and forecast, by Technique
8.3.6.4.3. Market size and forecast, by Application
8.3.6.4.4. Market size and forecast, by End User
8.3.6.5. Spain
8.3.6.5.1. Market size and forecast, by Product and Services
8.3.6.5.2. Market size and forecast, by Technique
8.3.6.5.3. Market size and forecast, by Application
8.3.6.5.4. Market size and forecast, by End User
8.3.6.6. Rest of Europe
8.3.6.6.1. Market size and forecast, by Product and Services
8.3.6.6.2. Market size and forecast, by Technique
8.3.6.6.3. Market size and forecast, by Application
8.3.6.6.4. Market size and forecast, by End User
8.4. Asia-Pacific
8.4.1. Key market trends, growth factors and opportunities
8.4.2. Market size and forecast, by Product and Services
8.4.3. Market size and forecast, by Technique
8.4.4. Market size and forecast, by Application
8.4.5. Market size and forecast, by End User
8.4.6. Market size and forecast, by country
8.4.6.1. Japan
8.4.6.1.1. Market size and forecast, by Product and Services
8.4.6.1.2. Market size and forecast, by Technique
8.4.6.1.3. Market size and forecast, by Application
8.4.6.1.4. Market size and forecast, by End User
8.4.6.2. China
8.4.6.2.1. Market size and forecast, by Product and Services
8.4.6.2.2. Market size and forecast, by Technique
8.4.6.2.3. Market size and forecast, by Application
8.4.6.2.4. Market size and forecast, by End User
8.4.6.3. India
8.4.6.3.1. Market size and forecast, by Product and Services
8.4.6.3.2. Market size and forecast, by Technique
8.4.6.3.3. Market size and forecast, by Application
8.4.6.3.4. Market size and forecast, by End User
8.4.6.4. Australia
8.4.6.4.1. Market size and forecast, by Product and Services
8.4.6.4.2. Market size and forecast, by Technique
8.4.6.4.3. Market size and forecast, by Application
8.4.6.4.4. Market size and forecast, by End User
8.4.6.5. South Korea
8.4.6.5.1. Market size and forecast, by Product and Services
8.4.6.5.2. Market size and forecast, by Technique
8.4.6.5.3. Market size and forecast, by Application
8.4.6.5.4. Market size and forecast, by End User
8.4.6.6. Rest of Asia-Pacific
8.4.6.6.1. Market size and forecast, by Product and Services
8.4.6.6.2. Market size and forecast, by Technique
8.4.6.6.3. Market size and forecast, by Application
8.4.6.6.4. Market size and forecast, by End User
8.5. LAMEA
8.5.1. Key market trends, growth factors and opportunities
8.5.2. Market size and forecast, by Product and Services
8.5.3. Market size and forecast, by Technique
8.5.4. Market size and forecast, by Application
8.5.5. Market size and forecast, by End User
8.5.6. Market size and forecast, by country
8.5.6.1. Brazil
8.5.6.1.1. Market size and forecast, by Product and Services
8.5.6.1.2. Market size and forecast, by Technique
8.5.6.1.3. Market size and forecast, by Application
8.5.6.1.4. Market size and forecast, by End User
8.5.6.2. Saudi Arabia
8.5.6.2.1. Market size and forecast, by Product and Services
8.5.6.2.2. Market size and forecast, by Technique
8.5.6.2.3. Market size and forecast, by Application
8.5.6.2.4. Market size and forecast, by End User
8.5.6.3. South Africa
8.5.6.3.1. Market size and forecast, by Product and Services
8.5.6.3.2. Market size and forecast, by Technique
8.5.6.3.3. Market size and forecast, by Application
8.5.6.3.4. Market size and forecast, by End User
8.5.6.4. Rest of LAMEA
8.5.6.4.1. Market size and forecast, by Product and Services
8.5.6.4.2. Market size and forecast, by Technique
8.5.6.4.3. Market size and forecast, by Application
8.5.6.4.4. Market size and forecast, by End User
Chapter 9: COMPETITIVE LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product mapping of top 10 player
9.4. Competitive dashboard
9.5. Competitive heatmap
9.6. Top player positioning, 2022
Chapter 10: COMPANY PROFILES
10.1. Freenome Holdings, Inc.
10.1.1. Company overview
10.1.2. Key executives
10.1.3. Company snapshot
10.1.4. Operating business segments
10.1.5. Product portfolio
10.1.6. Key strategic moves and developments
10.2. Natera, Inc.
10.2.1. Company overview
10.2.2. Key executives
10.2.3. Company snapshot
10.2.4. Operating business segments
10.2.5. Product portfolio
10.2.6. Business performance
10.2.7. Key strategic moves and developments
10.3. Agilent Technologies, Inc.
10.3.1. Company overview
10.3.2. Key executives
10.3.3. Company snapshot
10.3.4. Operating business segments
10.3.5. Product portfolio
10.3.6. Business performance
10.3.7. Key strategic moves and developments
10.4. Exact Sciences Corporation
10.4.1. Company overview
10.4.2. Key executives
10.4.3. Company snapshot
10.4.4. Operating business segments
10.4.5. Product portfolio
10.4.6. Business performance
10.4.7. Key strategic moves and developments
10.5. Illumina, Inc.
10.5.1. Company overview
10.5.2. Key executives
10.5.3. Company snapshot
10.5.4. Operating business segments
10.5.5. Product portfolio
10.5.6. Business performance
10.5.7. Key strategic moves and developments
10.6. F. Hoffmann-La Roche Ltd.
10.6.1. Company overview
10.6.2. Key executives
10.6.3. Company snapshot
10.6.4. Operating business segments
10.6.5. Product portfolio
10.6.6. Business performance
10.6.7. Key strategic moves and developments
10.7. Guardant Health
10.7.1. Company overview
10.7.2. Key executives
10.7.3. Company snapshot
10.7.4. Operating business segments
10.7.5. Product portfolio
10.7.6. Business performance
10.7.7. Key strategic moves and developments
10.8. InterVenn Biosciences
10.8.1. Company overview
10.8.2. Key executives
10.8.3. Company snapshot
10.8.4. Operating business segments
10.8.5. Product portfolio
10.8.6. Key strategic moves and developments
10.9. Thermo Fisher Scientific, Inc.
10.9.1. Company overview
10.9.2. Key executives
10.9.3. Company snapshot
10.9.4. Operating business segments
10.9.5. Product portfolio
10.9.6. Business performance
10.9.7. Key strategic moves and developments
10.10. Invitae Corporation
10.10.1. Company overview
10.10.2. Key executives
10.10.3. Company snapshot
10.10.4. Operating business segments
10.10.5. Product portfolio
10.10.6. Business performance
10.10.7. Key strategic moves and developments
10.11. NeoGenomics Laboratories
10.11.1. Company overview
10.11.2. Key executives
10.11.3. Company snapshot
10.11.4. Operating business segments
10.11.5. Product portfolio
10.11.6. Business performance
10.11.7. Key strategic moves and developments



List of Figures

LIST OF FIGURES
FIGURE 01. IN VITRO DIAGNOSTICS MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF IN VITRO DIAGNOSTICS MARKET,2022-2032
FIGURE 03. TOP IMPACTING FACTORS IN IN VITRO DIAGNOSTICS MARKET
FIGURE 04. TOP INVESTMENT POCKETS IN IN VITRO DIAGNOSTICS MARKET (2023-2032)
FIGURE 05. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 06. MODERATE THREAT OF NEW ENTRANTS
FIGURE 07. MODERATE THREAT OF SUBSTITUTES
FIGURE 08. MODERATE INTENSITY OF RIVALRY
FIGURE 09. HIGH BARGAINING POWER OF BUYERS
FIGURE 10. GLOBAL IN VITRO DIAGNOSTICS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11. IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2022 AND 2032(%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF IN VITRO DIAGNOSTICS MARKET FOR REAGENTS AND KITS, BY COUNTRY 2022 AND 2032(%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF IN VITRO DIAGNOSTICS MARKET FOR INSTRUMENTS, BY COUNTRY 2022 AND 2032(%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF IN VITRO DIAGNOSTICS MARKET FOR SOFTWARE AND SERVICES, BY COUNTRY 2022 AND 2032(%)
FIGURE 15. IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2022 AND 2032(%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF IN VITRO DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY COUNTRY 2022 AND 2032(%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF IN VITRO DIAGNOSTICS MARKET FOR HEMATOLOGY, BY COUNTRY 2022 AND 2032(%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF IN VITRO DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY 2022 AND 2032(%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF IN VITRO DIAGNOSTICS MARKET FOR TISSUE DIAGNOSTICS, BY COUNTRY 2022 AND 2032(%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF IN VITRO DIAGNOSTICS MARKET FOR CLINICAL CHEMISTRY, BY COUNTRY 2022 AND 2032(%)
FIGURE 21. COMPARATIVE SHARE ANALYSIS OF IN VITRO DIAGNOSTICS MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 22. IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2022 AND 2032(%)
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF IN VITRO DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY 2022 AND 2032(%)
FIGURE 24. COMPARATIVE SHARE ANALYSIS OF IN VITRO DIAGNOSTICS MARKET FOR CANCER, BY COUNTRY 2022 AND 2032(%)
FIGURE 25. COMPARATIVE SHARE ANALYSIS OF IN VITRO DIAGNOSTICS MARKET FOR CARDIAC DISEASES, BY COUNTRY 2022 AND 2032(%)
FIGURE 26. COMPARATIVE SHARE ANALYSIS OF IN VITRO DIAGNOSTICS MARKET FOR IMMUNE SYSTEM DISORDERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 27. COMPARATIVE SHARE ANALYSIS OF IN VITRO DIAGNOSTICS MARKET FOR NEPHROLOGICAL DISEASES, BY COUNTRY 2022 AND 2032(%)
FIGURE 28. COMPARATIVE SHARE ANALYSIS OF IN VITRO DIAGNOSTICS MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY 2022 AND 2032(%)
FIGURE 29. COMPARATIVE SHARE ANALYSIS OF IN VITRO DIAGNOSTICS MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 30. IN VITRO DIAGNOSTICS MARKET, BY END USER, 2022 AND 2032(%)
FIGURE 31. COMPARATIVE SHARE ANALYSIS OF IN VITRO DIAGNOSTICS MARKET FOR STANDALONE LABORATORIES, BY COUNTRY 2022 AND 2032(%)
FIGURE 32. COMPARATIVE SHARE ANALYSIS OF IN VITRO DIAGNOSTICS MARKET FOR HOSPITALS, BY COUNTRY 2022 AND 2032(%)
FIGURE 33. COMPARATIVE SHARE ANALYSIS OF IN VITRO DIAGNOSTICS MARKET FOR ACADEMIC AND MEDICAL SCHOOLS, BY COUNTRY 2022 AND 2032(%)
FIGURE 34. COMPARATIVE SHARE ANALYSIS OF IN VITRO DIAGNOSTICS MARKET FOR POINT OF CARE, BY COUNTRY 2022 AND 2032(%)
FIGURE 35. COMPARATIVE SHARE ANALYSIS OF IN VITRO DIAGNOSTICS MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 36. IN VITRO DIAGNOSTICS MARKET BY REGION, 2022 AND 2032(%)
FIGURE 37. U.S. IN VITRO DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
FIGURE 38. CANADA IN VITRO DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
FIGURE 39. MEXICO IN VITRO DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
FIGURE 40. GERMANY IN VITRO DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
FIGURE 41. FRANCE IN VITRO DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
FIGURE 42. UK IN VITRO DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
FIGURE 43. ITALY IN VITRO DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
FIGURE 44. SPAIN IN VITRO DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
FIGURE 45. REST OF EUROPE IN VITRO DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
FIGURE 46. JAPAN IN VITRO DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
FIGURE 47. CHINA IN VITRO DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
FIGURE 48. INDIA IN VITRO DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
FIGURE 49. AUSTRALIA IN VITRO DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
FIGURE 50. SOUTH KOREA IN VITRO DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
FIGURE 51. REST OF ASIA-PACIFIC IN VITRO DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
FIGURE 52. BRAZIL IN VITRO DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
FIGURE 53. SAUDI ARABIA IN VITRO DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
FIGURE 54. SOUTH AFRICA IN VITRO DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
FIGURE 55. REST OF LAMEA IN VITRO DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
FIGURE 56. TOP WINNING STRATEGIES, BY YEAR (2020-2023)
FIGURE 57. TOP WINNING STRATEGIES, BY DEVELOPMENT (2020-2023)
FIGURE 58. TOP WINNING STRATEGIES, BY COMPANY (2020-2023)
FIGURE 59. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 60. COMPETITIVE DASHBOARD
FIGURE 61. COMPETITIVE HEATMAP: IN VITRO DIAGNOSTICS MARKET
FIGURE 62. TOP PLAYER POSITIONING, 2022
FIGURE 63. NATERA, INC.: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 64. NATERA, INC.: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 65. AGILENT TECHNOLOGIES, INC.: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 66. AGILENT TECHNOLOGIES, INC.: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
FIGURE 67. AGILENT TECHNOLOGIES, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 68. AGILENT TECHNOLOGIES, INC.: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 69. EXACT SCIENCES CORPORATION: NET REVENUE, 2019-2021 ($MILLION)
FIGURE 70. EXACT SCIENCES CORPORATION: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 71. ILLUMINA, INC.: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 72. ILLUMINA, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 73. ILLUMINA, INC.: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 74. F. HOFFMANN-LA ROCHE LTD.: SALES REVENUE, 2020-2022 ($MILLION)
FIGURE 75. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 76. GUARDANT HEALTH: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 77. GUARDANT HEALTH: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 78. THERMO FISHER SCIENTIFIC, INC.: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 79. THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 80. THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 81. INVITAE CORPORATION: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 82. INVITAE CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 83. NEOGENOMICS LABORATORIES: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 84. NEOGENOMICS LABORATORIES: REVENUE SHARE BY SEGMENT, 2022 (%)

List of Tables

LIST OF TABLES
TABLE 01. GLOBAL IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2022-2032 ($MILLION)
TABLE 02. IN VITRO DIAGNOSTICS MARKET FOR REAGENTS AND KITS, BY REGION, 2022-2032 ($MILLION)
TABLE 03. IN VITRO DIAGNOSTICS MARKET FOR INSTRUMENTS, BY REGION, 2022-2032 ($MILLION)
TABLE 04. IN VITRO DIAGNOSTICS MARKET FOR SOFTWARE AND SERVICES, BY REGION, 2022-2032 ($MILLION)
TABLE 05. GLOBAL IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 06. IN VITRO DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY REGION, 2022-2032 ($MILLION)
TABLE 07. IN VITRO DIAGNOSTICS MARKET FOR HEMATOLOGY, BY REGION, 2022-2032 ($MILLION)
TABLE 08. IN VITRO DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY REGION, 2022-2032 ($MILLION)
TABLE 09. IN VITRO DIAGNOSTICS MARKET FOR TISSUE DIAGNOSTICS, BY REGION, 2022-2032 ($MILLION)
TABLE 10. IN VITRO DIAGNOSTICS MARKET FOR CLINICAL CHEMISTRY, BY REGION, 2022-2032 ($MILLION)
TABLE 11. IN VITRO DIAGNOSTICS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 12. GLOBAL IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 13. IN VITRO DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY REGION, 2022-2032 ($MILLION)
TABLE 14. IN VITRO DIAGNOSTICS MARKET FOR CANCER, BY REGION, 2022-2032 ($MILLION)
TABLE 15. IN VITRO DIAGNOSTICS MARKET FOR CARDIAC DISEASES, BY REGION, 2022-2032 ($MILLION)
TABLE 16. IN VITRO DIAGNOSTICS MARKET FOR IMMUNE SYSTEM DISORDERS, BY REGION, 2022-2032 ($MILLION)
TABLE 17. IN VITRO DIAGNOSTICS MARKET FOR NEPHROLOGICAL DISEASES, BY REGION, 2022-2032 ($MILLION)
TABLE 18. IN VITRO DIAGNOSTICS MARKET FOR GASTROINTESTINAL DISEASES, BY REGION, 2022-2032 ($MILLION)
TABLE 19. IN VITRO DIAGNOSTICS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 20. GLOBAL IN VITRO DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 21. IN VITRO DIAGNOSTICS MARKET FOR STANDALONE LABORATORIES, BY REGION, 2022-2032 ($MILLION)
TABLE 22. IN VITRO DIAGNOSTICS MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
TABLE 23. IN VITRO DIAGNOSTICS MARKET FOR ACADEMIC AND MEDICAL SCHOOLS, BY REGION, 2022-2032 ($MILLION)
TABLE 24. IN VITRO DIAGNOSTICS MARKET FOR POINT OF CARE, BY REGION, 2022-2032 ($MILLION)
TABLE 25. IN VITRO DIAGNOSTICS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 26. IN VITRO DIAGNOSTICS MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 27. NORTH AMERICA IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2022-2032 ($MILLION)
TABLE 28. NORTH AMERICA IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 29. NORTH AMERICA IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 30. NORTH AMERICA IN VITRO DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 31. NORTH AMERICA IN VITRO DIAGNOSTICS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 32. U.S. IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2022-2032 ($MILLION)
TABLE 33. U.S. IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 34. U.S. IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 35. U.S. IN VITRO DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 36. CANADA IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2022-2032 ($MILLION)
TABLE 37. CANADA IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 38. CANADA IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 39. CANADA IN VITRO DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 40. MEXICO IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2022-2032 ($MILLION)
TABLE 41. MEXICO IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 42. MEXICO IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 43. MEXICO IN VITRO DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 44. EUROPE IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2022-2032 ($MILLION)
TABLE 45. EUROPE IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 46. EUROPE IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 47. EUROPE IN VITRO DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 48. EUROPE IN VITRO DIAGNOSTICS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 49. GERMANY IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2022-2032 ($MILLION)
TABLE 50. GERMANY IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 51. GERMANY IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 52. GERMANY IN VITRO DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 53. FRANCE IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2022-2032 ($MILLION)
TABLE 54. FRANCE IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 55. FRANCE IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 56. FRANCE IN VITRO DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 57. UK IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2022-2032 ($MILLION)
TABLE 58. UK IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 59. UK IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 60. UK IN VITRO DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 61. ITALY IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2022-2032 ($MILLION)
TABLE 62. ITALY IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 63. ITALY IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 64. ITALY IN VITRO DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 65. SPAIN IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2022-2032 ($MILLION)
TABLE 66. SPAIN IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 67. SPAIN IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 68. SPAIN IN VITRO DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 69. REST OF EUROPE IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2022-2032 ($MILLION)
TABLE 70. REST OF EUROPE IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 71. REST OF EUROPE IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 72. REST OF EUROPE IN VITRO DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 73. ASIA-PACIFIC IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2022-2032 ($MILLION)
TABLE 74. ASIA-PACIFIC IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 75. ASIA-PACIFIC IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 76. ASIA-PACIFIC IN VITRO DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 77. ASIA-PACIFIC IN VITRO DIAGNOSTICS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 78. JAPAN IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2022-2032 ($MILLION)
TABLE 79. JAPAN IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 80. JAPAN IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 81. JAPAN IN VITRO DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 82. CHINA IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2022-2032 ($MILLION)
TABLE 83. CHINA IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 84. CHINA IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 85. CHINA IN VITRO DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 86. INDIA IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2022-2032 ($MILLION)
TABLE 87. INDIA IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 88. INDIA IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 89. INDIA IN VITRO DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 90. AUSTRALIA IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2022-2032 ($MILLION)
TABLE 91. AUSTRALIA IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 92. AUSTRALIA IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 93. AUSTRALIA IN VITRO DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 94. SOUTH KOREA IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2022-2032 ($MILLION)
TABLE 95. SOUTH KOREA IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 96. SOUTH KOREA IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 97. SOUTH KOREA IN VITRO DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 98. REST OF ASIA-PACIFIC IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2022-2032 ($MILLION)
TABLE 99. REST OF ASIA-PACIFIC IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 100. REST OF ASIA-PACIFIC IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 101. REST OF ASIA-PACIFIC IN VITRO DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 102. LAMEA IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2022-2032 ($MILLION)
TABLE 103. LAMEA IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 104. LAMEA IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 105. LAMEA IN VITRO DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 106. LAMEA IN VITRO DIAGNOSTICS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 107. BRAZIL IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2022-2032 ($MILLION)
TABLE 108. BRAZIL IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 109. BRAZIL IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 110. BRAZIL IN VITRO DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 111. SAUDI ARABIA IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2022-2032 ($MILLION)
TABLE 112. SAUDI ARABIA IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 113. SAUDI ARABIA IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 114. SAUDI ARABIA IN VITRO DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 115. SOUTH AFRICA IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2022-2032 ($MILLION)
TABLE 116. SOUTH AFRICA IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 117. SOUTH AFRICA IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 118. SOUTH AFRICA IN VITRO DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 119. REST OF LAMEA IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2022-2032 ($MILLION)
TABLE 120. REST OF LAMEA IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 121. REST OF LAMEA IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 122. REST OF LAMEA IN VITRO DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 123. FREENOME HOLDINGS, INC.: KEY EXECUTIVES
TABLE 124. FREENOME HOLDINGS, INC.: COMPANY SNAPSHOT
TABLE 125. FREENOME HOLDINGS, INC.: PRODUCT SEGMENTS
TABLE 126. FREENOME HOLDINGS, INC.: PRODUCT PORTFOLIO
TABLE 127. FREENOME HOLDINGS, INC.: KEY STRATERGIES
TABLE 128. NATERA, INC.: KEY EXECUTIVES
TABLE 129. NATERA, INC.: COMPANY SNAPSHOT
TABLE 130. NATERA, INC.: PRODUCT SEGMENTS
TABLE 131. NATERA, INC.: PRODUCT PORTFOLIO
TABLE 132. NATERA, INC.: KEY STRATERGIES
TABLE 133. AGILENT TECHNOLOGIES, INC.: KEY EXECUTIVES
TABLE 134. AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
TABLE 135. AGILENT TECHNOLOGIES, INC.: PRODUCT SEGMENTS
TABLE 136. AGILENT TECHNOLOGIES, INC.: PRODUCT PORTFOLIO
TABLE 137. AGILENT TECHNOLOGIES, INC.: KEY STRATERGIES
TABLE 138. EXACT SCIENCES CORPORATION: KEY EXECUTIVES
TABLE 139. EXACT SCIENCES CORPORATION: COMPANY SNAPSHOT
TABLE 140. EXACT SCIENCES CORPORATION: PRODUCT SEGMENTS
TABLE 141. EXACT SCIENCES CORPORATION: PRODUCT PORTFOLIO
TABLE 142. EXACT SCIENCES CORPORATION: KEY STRATERGIES
TABLE 143. ILLUMINA, INC.: KEY EXECUTIVES
TABLE 144. ILLUMINA, INC.: COMPANY SNAPSHOT
TABLE 145. ILLUMINA, INC.: PRODUCT SEGMENTS
TABLE 146. ILLUMINA, INC.: PRODUCT PORTFOLIO
TABLE 147. ILLUMINA, INC.: KEY STRATERGIES
TABLE 148. F. HOFFMANN-LA ROCHE LTD.: KEY EXECUTIVES
TABLE 149. F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
TABLE 150. F. HOFFMANN-LA ROCHE LTD.: PRODUCT SEGMENTS
TABLE 151. F. HOFFMANN-LA ROCHE LTD.: PRODUCT PORTFOLIO
TABLE 152. F. HOFFMANN-LA ROCHE LTD.: KEY STRATERGIES
TABLE 153. GUARDANT HEALTH: KEY EXECUTIVES
TABLE 154. GUARDANT HEALTH: COMPANY SNAPSHOT
TABLE 155. GUARDANT HEALTH: PRODUCT SEGMENTS
TABLE 156. GUARDANT HEALTH: PRODUCT PORTFOLIO
TABLE 157. GUARDANT HEALTH: KEY STRATERGIES
TABLE 158. INTERVENN BIOSCIENCES: KEY EXECUTIVES
TABLE 159. INTERVENN BIOSCIENCES: COMPANY SNAPSHOT
TABLE 160. INTERVENN BIOSCIENCES: PRODUCT SEGMENTS
TABLE 161. INTERVENN BIOSCIENCES: PRODUCT PORTFOLIO
TABLE 162. INTERVENN BIOSCIENCES: KEY STRATERGIES
TABLE 163. THERMO FISHER SCIENTIFIC, INC.: KEY EXECUTIVES
TABLE 164. THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
TABLE 165. THERMO FISHER SCIENTIFIC, INC.: PRODUCT SEGMENTS
TABLE 166. THERMO FISHER SCIENTIFIC, INC.: PRODUCT PORTFOLIO
TABLE 167. THERMO FISHER SCIENTIFIC, INC.: KEY STRATERGIES
TABLE 168. INVITAE CORPORATION: KEY EXECUTIVES
TABLE 169. INVITAE CORPORATION: COMPANY SNAPSHOT
TABLE 170. INVITAE CORPORATION: PRODUCT SEGMENTS
TABLE 171. INVITAE CORPORATION: PRODUCT PORTFOLIO
TABLE 172. INVITAE CORPORATION: KEY STRATERGIES
TABLE 173. NEOGENOMICS LABORATORIES: KEY EXECUTIVES
TABLE 174. NEOGENOMICS LABORATORIES: COMPANY SNAPSHOT
TABLE 175. NEOGENOMICS LABORATORIES: SERVICE SEGMENTS
TABLE 176. NEOGENOMICS LABORATORIES: PRODUCT PORTFOLIO
TABLE 177. NEOGENOMICS LABORATORIES: KEY STRATERGIES